Cell Fate in Cancer
The cell is the basic unit of life. The attainment of a nucleus to house the genetic material is thought to have provided a distinct advantage to the evolving cell, ultimately allowing the emergence of differentiated, specialized cells. Hoarding evidence suggests that genomes are organized non-randomly into complex 3D configurations that vary according to cell type, stage of development, differentiation and disease status. The principles, which guide higher order organization, the mechanisms responsible for establishment, maintenance and alterations of higher order genome, and the functional consequences of aberrant genome and nuclear organization, have become zones of intense interest. The higher-order spatial and temporal organization of genomes in the cell nucleus is rapidly evolving as a driver of biological function in differentiation, development and disease and the incorporation of information on higher order genome organization add an additional level of complexity in our understanding of genome regulation. DNA sequence variations and biochemical sequence modifications co-define cell fate. Through exploration of cancer genomes, new gene categories have been identified that imply novel underlying mechanisms related to epigenetics, transcriptional processes and cell differentiation. These contrivances are of major prominence in tumorigenesis and cancer therapy failure.
Differentiated tumor cells may present different elevated cell potencies. Thus, tumor heterogeneity may be presented as a certain three-dimensional space that is defined by the range of three key features – cell potency, cell lineage specificity and variance. Cell fate dynamics and the resulting cell population diversity and evolution during tumorigenesis and cancer drug treatment have been correlated with cellular responses to environmental stress. This might provide new insights for understanding tumorigenesis and new strategies that target whole cell system dynamics for cancer therapy.
- Oncoproteins and Cellular Targets
- Emerging Concepts and Technologies
- Genomics, Biomarkers and clinical trials
- Integrative Science and Translation
Related Conference of Cell Fate in Cancer
14th International Conference on Human Genetics and Genetic Diseases
ESSO-EYSAC Course on Colorectal Cancer Surgery Ljubljana Slovenia
Miami 2016 Winter Symposium Miami United States of America
2nd AMDI International Biohealth Sciences Conference 2016 Penang Malaysia
ESSO Course on the Management of High Risk Patients for Breast Cancer A Multidisciplinary Approach Berlin Germany
3rd International Conference on Biotechnology and Bioinformatics ICBB-2016 Pune India
New and Emerging Trends In Oncology 2016 Hyderabad India
International Conference on Radiation Research Impact on Human Health and Environment Mumbai India
3rd Annual International Conference on Advances in Cancer Medical Research ACMR 2016 Singapore Singapore
The Probiotics Congress Asia Kuala Lumpur Malaysia
Molecular Medicine Tri-Con 2016 San Francisco United States of America
Cell Fate in Cancer Conference Speakers
Recommended Sessions
Related Journals
Are you interested in
- 3D Bio-Printing and Organ Printing - Stemgen 2024 (UK)
- 3D bioprinting using Stem Cells - Stemgen 2024 (UK)
- Advanced Gene Therapeutics - WORLD CELL THERAPY 2024 (UK)
- Advances in Cell Therapy Research - REGENERATIVE MED MEET 2024 (UK)
- Applications of Stem Cells - Stemgen 2024 (UK)
- Applications of Tissue engineering & Regenerative Medicine - REGENERATIVE MED MEET 2024 (UK)
- Bio Banking - Stemgen 2024 (UK)
- Bio Banking Stem cell - Stem Cell 2024 (Ireland)
- Biochemical Genetics - Human Genetics 2024 (Canada)
- Bioengineering Therapeutics - WORLD CELL THERAPY 2024 (UK)
- Bioinformatics, Machine learning and Statistical methods - HUMAN GENETICS MEET 2024 (UAE)
- Biologic Scaffolds for Regenerative Medicine - REGENERATIVE MED MEET 2024 (UK)
- Biomaterials & Bioengineering - REGENERATIVE MED MEET 2024 (UK)
- Bone Marrow Transplantation - Stem Cell 2024 (Ireland)
- Bone Marrow Transplantation - Stemgen 2024 (UK)
- Cancer Genetics - Human Genetics 2024 (Canada)
- Cancer Stem Cell and Oncology - Stemgen 2024 (UK)
- Cancer Therapies - WORLD CELL THERAPY 2024 (UK)
- Cancer, Cardiovascular Diseases and Genetics - HUMAN GENETICS MEET 2024 (UAE)
- Cell and Gene Therapy - Stemgen 2024 (UK)
- Cell Culture and Bio processing - WORLD CELL THERAPY 2024 (UK)
- Cell Science and Stem Cell Research - WORLD CELL THERAPY 2024 (UK)
- Cell Therapy and Regenerative Medicine Market - REGENERATIVE MED MEET 2024 (UK)
- Cell Therapy in Pulmonology - WORLD CELL THERAPY 2024 (UK)
- Cellular Therapies - WORLD CELL THERAPY 2024 (UK)
- Clinical Genetics - Human Genetics 2024 (Canada)
- Clinical Genetics and Novel Therapies of Genetic Diseases - HUMAN GENETICS MEET 2024 (UAE)
- Clinical Methods - Stem Cell 2024 (Ireland)
- Clinical Trials and Research in Cell and Gene Therapies - WORLD CELL THERAPY 2024 (UK)
- Clinical Trials on Cell Therapy and Regenerative Medicine - REGENERATIVE MED MEET 2024 (UK)
- Cytogenetics - Human Genetics 2024 (Canada)
- Dental Stem Cell - Stemgen 2024 (UK)
- Dental Stem Cells - Stem Cell 2024 (Ireland)
- Developmental Genetics - Human Genetics 2024 (Canada)
- Diabetes Gene Therapy - WORLD CELL THERAPY 2024 (UK)
- Effect of Aging on Stem Cells - Stemgen 2024 (UK)
- Epigenetics - Human Genetics 2024 (Canada)
- Epigenetics and Gene Regulation - HUMAN GENETICS MEET 2024 (UAE)
- Ethical & Social Implications of Gene Editing - Human Genetics 2024 (Canada)
- Evolutionary and Population Genetics - HUMAN GENETICS MEET 2024 (UAE)
- Functional Genomics and Transcriptomics - HUMAN GENETICS MEET 2024 (UAE)
- Gene Cloning and Mapping - HUMAN GENETICS MEET 2024 (UAE)
- Gene Therapy - Human Genetics 2024 (Canada)
- Gene Therapy - REGENERATIVE MED MEET 2024 (UK)
- Gene Therapy and Genetic Counseling - Human Genetics 2024 (Canada)
- Genetic Counseling - Human Genetics 2024 (Canada)
- Genetic Disorders - Human Genetics 2024 (Canada)
- Genetic Vaccines - WORLD CELL THERAPY 2024 (UK)
- Genomic Medicine & Molecular Diagnostics - Human Genetics 2024 (Canada)
- Genomics - Human Genetics 2024 (Canada)
- HIV Gene Therapy - WORLD CELL THERAPY 2024 (UK)
- Human Gene Therapy - WORLD CELL THERAPY 2024 (UK)
- Human Genetic Engineering - Human Genetics 2024 (Canada)
- Human genetics - Human Genetics 2024 (Canada)
- Human Genetics - HUMAN GENETICS MEET 2024 (UAE)
- Immunogenetics - Human Genetics 2024 (Canada)
- Immunotherapy - REGENERATIVE MED MEET 2024 (UK)
- Immunotherapy - WORLD CELL THERAPY 2024 (UK)
- Medical Genetics - Human Genetics 2024 (Canada)
- Models of Regeneration - REGENERATIVE MED MEET 2024 (UK)
- Molecular and Cytogenetics - HUMAN GENETICS MEET 2024 (UAE)
- Molecular Effects of Genetic Variation - HUMAN GENETICS MEET 2024 (UAE)
- Molecular Epigenetics - WORLD CELL THERAPY 2024 (UK)
- Molecular Genetics - Human Genetics 2024 (Canada)
- Molecular Phenotyping and Omics Technologies - HUMAN GENETICS MEET 2024 (UAE)
- Mutation Detection and Analysis - HUMAN GENETICS MEET 2024 (UAE)
- Nano-Therapy - WORLD CELL THERAPY 2024 (UK)
- Nanotechnology in Cell Therapy and Regenerative Medicine - REGENERATIVE MED MEET 2024 (UK)
- Nanotechnology in Stem Cell - WORLD CELL THERAPY 2024 (UK)
- Neurodegenerative Disease - Stem Cell 2024 (Ireland)
- New Market Trends, R&D on Stem Cells - Stemgen 2024 (UK)
- Novel Approaches guided in Tissue Engineering - REGENERATIVE MED MEET 2024 (UK)
- Novel Stem Cell Therapy - WORLD CELL THERAPY 2024 (UK)
- Nutritional Genomics - Human Genetics 2024 (Canada)
- Oncogenomics and Cancer Heredity - Human Genetics 2024 (Canada)
- Orthopedics, Sports Medicine and Regenerative Rehabilitation - REGENERATIVE MED MEET 2024 (UK)
- Pharmacogenetics - Human Genetics 2024 (Canada)
- Pharmacogenomics - HUMAN GENETICS MEET 2024 (UAE)
- Population Genetics - Human Genetics 2024 (Canada)
- Regeneration and Therapeutics - Stem Cell 2024 (Ireland)
- Regenerative Medicine - Stemgen 2024 (UK)
- Regenerative Medicine in Aging, Dermatology and Plastic Surgery - REGENERATIVE MED MEET 2024 (UK)
- Regenerative Medicine Research - REGENERATIVE MED MEET 2024 (UK)
- Regenerative Medicine research and development - Stemgen 2024 (UK)
- Regenerative Therapy in Osteoarthritis - Stemgen 2024 (UK)
- Research and Development of Stem Cell & Regenerative Drugs - Stem Cell 2024 (Ireland)
- Sickle cell Anaemia Genomics - HUMAN GENETICS MEET 2024 (UAE)
- Skin Cell Therapy - WORLD CELL THERAPY 2024 (UK)
- Stem Cell and Tissue Engineering - Stemgen 2024 (UK)
- Stem Cell Animal Applications - Stem Cell 2024 (Ireland)
- Stem Cell Apoptosis and Signal Transmission - Stem Cell 2024 (Ireland)
- Stem Cell Embryology - Stem Cell 2024 (Ireland)
- Stem cell engineering - WORLD CELL THERAPY 2024 (UK)
- Stem Cell in Cardiovascular Disease - WORLD CELL THERAPY 2024 (UK)
- Stem Cell in Drug Development - WORLD CELL THERAPY 2024 (UK)
- Stem Cell in Drug Discovery - Stem Cell 2024 (Ireland)
- Stem Cell Research - Human Genetics 2024 (Canada)
- Stem Cell Research and Therapy - Human Genetics 2024 (Canada)
- Stem Cell Therapies - WORLD CELL THERAPY 2024 (UK)
- Stem Cell Therapy - Stemgen 2024 (UK)
- Stem cell Transplantation - HUMAN GENETICS MEET 2024 (UAE)
- Stem Cell Transplantation - Stem Cell 2024 (Ireland)
- Stem Cell Transplantation to Avoid Cancer - Stemgen 2024 (UK)
- Stem Cells - Stem Cell 2024 (Ireland)
- Stem Cells and Disease Modelling - Stemgen 2024 (UK)
- The use of Stem Cells for COVID-19 Therapy - Stemgen 2024 (UK)
- Theories of Aging in Stem Biology - Stem Cell 2024 (Ireland)
- Tissue Engineering - Stem Cell 2024 (Ireland)
- Tissue Science and Engineering - REGENERATIVE MED MEET 2024 (UK)
- Translational Medicine - HUMAN GENETICS MEET 2024 (UAE)
- Translational Research in Stem Cell Assessments - Stem Cell 2024 (Ireland)
- Viral gene therapy - WORLD CELL THERAPY 2024 (UK)